Stay updated on Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial
Sign up to get notified when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.

Latest updates to the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a minor metadata update to the study record.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe study record now lists the Study Chair and Investigators, including BioXcel Therapeutics personnel, and shows the latest update date of 2026-08-11. It also removes older update dates from 2023.SummaryDifference0.5%

- Check41 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the study page, indicating a minor update to the page’s content or layout rather than changes to study data.SummaryDifference0.1%

- Check56 days agoChange DetectedThe revision label on the page updated from v3.6.3 to v3.6.4, reflecting a system/template update rather than changes to study details.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, signaling a minor update to the page version. This change does not alter the study details or user-facing content.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page's revision history shows a new version labeled v3.6.2, replacing the previous v3.6.0, indicating a minor metadata update to the study record.SummaryDifference0.1%

Stay in the know with updates to Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.